AbbVie Begin Period Cash Flow from 2010 to 2025
| ABBV Stock | USD 192.97 1.22 0.64% |
Begin Period Cash Flow | First Reported 2011-03-31 | Previous Quarter 18.1 B | Current Value 13.1 B | Quarterly Volatility 7.3 B |
Check AbbVie financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AbbVie's main balance sheet or income statement drivers, such as Depreciation And Amortization of 10.5 B, Interest Expense of 2.7 B or Selling General Administrative of 7.8 B, as well as many indicators such as Price To Sales Ratio of 3.39, Dividend Yield of 0.0289 or PTB Ratio of 17.2. AbbVie financial statements analysis is a perfect complement when working with AbbVie Valuation or Volatility modules.
AbbVie | Begin Period Cash Flow |
Latest AbbVie's Begin Period Cash Flow Growth Pattern
Below is the plot of the Begin Period Cash Flow of AbbVie Inc over the last few years. It is the amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities. AbbVie's Begin Period Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in AbbVie's overall financial position and show how it may be relating to other accounts over time.
| Begin Period Cash Flow | 10 Years Trend |
|
Begin Period Cash Flow |
| Timeline |
AbbVie Begin Period Cash Flow Regression Statistics
| Arithmetic Mean | 8,797,731,463 | |
| Geometric Mean | 2,151,357,950 | |
| Coefficient Of Variation | 102.94 | |
| Mean Deviation | 4,457,091,521 | |
| Median | 8,449,000,000 | |
| Standard Deviation | 9,056,719,934 | |
| Sample Variance | 82024176T | |
| Range | 39.9B | |
| R-Value | 0.43 | |
| Mean Square Error | 71586289.9T | |
| R-Squared | 0.19 | |
| Significance | 0.1 | |
| Slope | 819,172,072 | |
| Total Sum of Squares | 1230362639.4T |
AbbVie Begin Period Cash Flow History
About AbbVie Financial Statements
AbbVie investors use historical fundamental indicators, such as AbbVie's Begin Period Cash Flow, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in AbbVie. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Begin Period Cash Flow | 10.6 B | 8.9 B |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for AbbVie Stock Analysis
When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.